Interleukin 2 infusion induces haemopoietic growth factors and modifies marrow regeneration after chemotherapy or autologous marrow transplantation

British Journal of Haematology

Volumn 77, Issue 2, 1991, Pages 237-244

  Heslop, Helen E ^a,b   Duncombe, Andrew S ^a   Reittie, Joyce E ^a   Bello‐Fernandez, Concha ^a   Gottlieb, David J ^a   Prentice, H Grant ^a   Mehta, Atul B ^a   Hoffbrand, A Victor ^a   Brenner, Malcolm K ^a,b,c  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLONY STIMULATING FACTOR; GAMMA INTERFERON; INTERLEUKIN 2; TUMOR NECROSIS FACTOR;

ADULT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; LEUKEMIA; MALE; NEUTROPHIL; PRIORITY JOURNAL;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; BLOOD CELL COUNT; BONE MARROW; BONE MARROW TRANSPLANTATION; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEMATOPOIETIC CELL GROWTH FACTORS; HUMAN; INTERLEUKIN-2; INTERLEUKIN-3; LEUKEMIA, MYELOID; MALE; MIDDLE AGE; MULTIPLE MYELOMA; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0025963705     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.1991.tb07983.x     Document Type: Article

References (33)

1. Tumor necrosis factor infusions have a procoagulant effect on the hemostatic mechanism of humans
2. Human tumor infiltrating lymphocytes. Analysis of lymphokine mRNA expression and relevance to cancer immunotherapy
3. Enhancement of monoclonal antibody dependent cell‐mediated cytotoxicity by IL2 and GMCSF
4. The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferonγ
5. Production of hematopoietic colony‐stimulating factors by human natural killer cells
6. Granulocyte macrophage colony stimulating factor induced changes in cellular adhesion molecule expression and adhesion to endothelium: in‐vitro and in‐vivo studies in man
7. Human IL3 and GM‐CSF act synergistically in stimulating hematopoiesis in primates
8. Gamma interferon and tumour necrosis factor production following bone marrow transplantation is augmented by exposure to marrow fibroblasts infected with CMV
9. Human fibroblasts produce granulocyte‐CSF, macrophage‐CSF, and granulocyte‐macrophage‐CSF following stimulation by interleukin‐1 and poly(rI).Poly(rC)
10. Effect of recombinant interferons alpha and gamma on human bone marrow‐derived megakaryocytic progenitor cells
11. Effects of recombinant Interleukin 2 administration on cytotoxic effector function following intensive chemoradiotherapy for hematological malignancy
12. A phase I trial of recombinant Interleukin 2 following high dose chemoradiotherapy for haematological malignancy: applicability to the elimination of minimal residual disease
13. Interleukin‐2 modulates the expression of lymphocyte function‐associated antigen‐one (LFA–1) and pi 50, 95 during the generation of lymphokine‐activated killer (LAK) cells
14. Interleukin 1 stimulates T lymphocytes to produce granulocyte‐monocyte colony‐stimulating factor
15. In vitro analysis of the interactions of recombinant IL2 with regenerating lymphoid and myeloid cells after allogeneic marrow transplantation
16. In vivo induction of gamma interferon and tumour necrosis factor by Interleukin 2 infusion following intensive chemotherapy or autologous marrow transplantation
17. Induction of endogenous cytokine mRNA in circulating peripheral blood mononuclear cells by IL2 administration to cancer patients
18. An acquired chemotactic defect in neutrophils from patients receiving Interleukin‐2 immunotherapy
19. Recombinant human TNF‐α stimulates production of granulocyte colony‐stimulating factor
20. Induction of NK activity against fresh human leukemia in culture with Interleukin 2
21. Enhancement of release of granulocyte‐ and granulocyte‐macrophage colony‐stimulating factors from phytohemaggiutinin‐stimulated sorted subsets of human T lymphocytes by recombinant human tumor necrosis factor‐a: synergism with recombinant human IFN‐γ
22. Recombinant human TNF induces production of granulocyte‐monocyte colony‐stimulating factor
23. Expression of human Interleukin‐3 (multi‐CSF) is restricted to human lymphocytes and T‐cell tumor lines
24. Human gamma interferon enhances release from phytohemagglutanin‐stimulated T4 lymphocytes of activities that stimulate colony formation by granulocyte‐macrophage, erythroid and multiprogenitor cells
25. Cytotoxic effects of tumour necrosis factor and gamma‐interferon on acute myeloid leukaemia blasts
26. Interleukin 1 induces cultured human endothelial cell production of granulocyte‐macrophage colony‐stimulating factor
27. Nosocomial sepsis associated with Interleukin 2
28. Inhibition of human granulocyte‐macrophage colony formation by Interleukin 2‐treated lymphocytes
29. Myelostimulatory activity of recombinant human Interleukin 2 in mice
30. Granulocyte‐macrophage colony‐stimulating factor and Interleukin 3 mRNAs are produced by a small fraction of blood mononuclear cells
31. Human IL‐2 multi‐CSF): identification by expression cloning of a novel hematopoietic growth factor related to murine IL‐3
32. Interleukin 1 stimulates fibroblasts to produce granulocyte‐macrophage colony‐stimulating activity and prostaglandin E2